Answers are grounded in this paper and cite their sources.
Abstract Organic extract plays a crucial role in our lives, providing food and pharmaceuticals. Extracts from plants showed anti-inflammatory potential in an in vitro macrophage model, and their anticancer activities were assessed using real-time PCR and MTT assays. Major compounds in the n-hexane (AR-H) and the ethyl acetate (AR-E) Aristolochia olivieri extracts was n-hexadecanoic acid, and the major component of the methanol extract (AR-M) was pentacosane. The AR-M extract had a strong ability to induce mRNA expression of an inflammatory cytokine, IL-6, as an M1-like macrophage subset compared to the negative control (DMSO-treated cells). In contrast, AR-E treatment showed strong anti-inflammatory activity against macrophages. The AR-H extract had a moderate inflammatory effect against macrophages. The IC50 results of the anticancer assays ranged from 58.29 to 451.03 µg/mL for the three extracts. The anticancer action of the AR-E extract against U-87MG cells was higher (58.29 µg/mL) than that of AR-H and AR-M (156.38 and 196.14 µg/mL, respectively). The greater cytotoxicity effect observed with the AR-E extract against U-87MG can be linked to its high content of hexadecanoic acid (32.49%) and linolenic acid (12.90%). In this study to fully understand the therapeutic potential and uses as food to confirm safety.
No takes yet. Share an insight, caveat, or question.
Fuad O. Abdullah (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: